111 Somerset Road, #06-20
TripleOne Somerset
Singapore
As economies around the world are suffering from the impact of Covid-19, businesses are experiencing losses, workers are without jobs, and many face the challenge of a complete upheaval of lifestyle. However, pharmaceutical companies are taking center stage in the Covid-19 fight, and one of these is a Korean conglomerate, SK Group, is seeing growth on the stock market and a new burst of innovation in the infectious disease landscape as the race for treatment approval for a Covid-19 therapy takes off.
SK Group, the 2nd largest group in Korea after Samsung with an annual revenue of $213.6B in 2018, has two arms of pharmaceutical subsidiaries, SK Pharmteco, the pharmaceutical intermediate, and API manufacturer & SK Biopharmaceuticals, the new drug development.
With support from JAS APAC & JAS Worldwide, JAS Korea has become a contracted freight forwarding business partner for SK Biotek as of last December, then after months of implementation period, JAS has been handling various types of Pharmaceutical export shipments by Air & Ocean to additional International Pharmaceutical companies in Europe.
Due to the nature of the cargo, pharmaceutical products, they must be mostly carried by air freight, using special equipment such as dry ice gel/ ice pack, cool/ reefer truck, temperature-controlled storage, and even RKNs which require thorough knowledge and experience to handle such a commodity properly and in a timely manner.
The RKN e1 is a one pallet size container, based on a second-generation active temperature control system and utilizes compressor cooling and electric heating technology, to meet the requirements of the pharmaceutical industry for smaller air shipments.
The RKN e1 container maintains product temperatures in the +2 to +8 °C range, controlled room temperature (+15 to +25 °C) range, JAS Korea has successfully arranged 11 RKN e1 for its door to door delivery to a Spanish Pharmaceutical consignee with Dap term in March, when the Pandemic was in the peak.
SK Pharmteco’s subsidiary, AMPAC is one of the strategic partners to a U.S. public benefit drug manufacturing corporation, which recently received federal government funding of $354 million for advanced manufacturing of America’s most essential medicines at risk of shortage, including those for the COVID-19 response. With its strategic partners, it has initiated manufacturing chemical precursor ingredients, active pharmaceutical ingredients (APIs), and finished dosage forms for over a dozen essential medicines to treat hospitalized patients with COVID-19-related illnesses.
SK Biotek will supply pharmaceutical intermediates to AMPAC and has appointed JAS Korea as the logistics provider for this project. The 1st air shipment was exported to AMPAC in California, USA by suing 5 x RKN e 1 in close cooperation with JAS San Francisco on June 15th, all 5 x RKNs were successfully delivered to AMPAC on the next day. After the ingredient’s analysis main orders will be placed shortly and JAS will continue to handle this business. Next opportunity will be export business out of AMPAC to overseas with the finished products.
JAS Korea is continuing to expand their reputation as the perfect solution for the transportation of pharmaceutical products in the market with these continued efforts excellent team-work. We are sure JAS will be leading the market in a near future.
Once again, Parker Hannifin has recognized JAS with its International Freight Forwarder of the Year award for 2025. Parker Hannifin, a Fortune 250 global leader in motion and control technologies, serves a wide range of industries including aerospace, climate control, filtration, and automation. The company highlighted JAS’s cybersecurity and sustainability efforts, on-time delivery, and commitment to continuous improvement as key reasons for selecting JAS as this year’s recipient.
This marks the third time JAS has been honored with this award, having previously received the recognition in 2017 and 2020. Being named International Freight Forwarder of the Year once again underscores JAS’s ongoing commitment to delivering customer value, consistent partnership, and excellence in global logistics solutions.
We would like to remind our customers of the implementation of the Import Control System 2 (ICS2), the European Union’s enhanced pre-arrival safety and security program for cargo entering or transiting through EU Member States, as well as Norway, Switzerland, and Northern Ireland. Effective 1 September 2025, ICS2 became mandatory across all modes of transport—air, ocean, road, and rail. This regulation requires the submission of detailed shipment data via an Entry Summary Declaration (ENS) prior to cargo arrival at the EU border.
What You Need to Know ICS2 is designed to:
Your Responsibilities as a Shipper or Cargo Owner
To ensure compliance and avoid disruptions, please take note of the following obligations:
Data Submission Requirements
You must provide:
Filing Responsibilities
Non-Compliance Risks Failure to comply with ICS2 requirements may lead to:
Recommended Actions to prepare for ICS2 compliance:
Technology & Support
In response to the EU’s Import Control System 2 (ICS2) requirements, we want to reassure our customers that our experienced staff and systems are fully prepared to manage the necessary data submissions and compliance procedures on your behalf. To support this service and ensure the smooth processing of your shipments, a compliance handling fee will apply. This fee covers the administrative effort and data validation to meet the latest EU regulations efficiently and accurately.
We are also investing in digital tools and customs platforms to automate data validation and submission, reducing manual errors and ensuring timely compliance. If you have any questions or would like guidance on preparing your shipment data, please contact your JAS account representative.
JAS has been awarded a Silver Medal in the EcoVadis sustainability assessment, achieving a score of 75 points. This marks a 15-point improvement from last year’s Bronze rating and places JAS among the top 15% of companies assessed globally.
EcoVadis is one of the world’s most trusted providers of business sustainability ratings, evaluating over 130,000 companies across four categories: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
In the latest assessment, JAS received particularly strong recognition in the Environment category (91/100), reflecting our focus on decarbonization, responsible resource use, and advancing sustainable logistics solutions. JAS also recorded solid progress in Labor & Human Rights, Ethics, and Sustainable Procurement, showing how JAS is working to embed responsible practices across its global operations and supply chain.
Andrea Goeman, SVP Sustainability, JAS, commented:
“We are proud to see our progress recognized with the EcoVadis Silver Medal. This achievement reflects the collaboration across our global teams and our strong commitment to building a more sustainable future for our customers, partners, and communities. While this is an important milestone, we will continue to strengthen our practices to further improve our performance in the years ahead.”
With a score of 75 points, JAS now ranks in the 92nd percentile of all companies assessed by EcoVadis. This performance not only supports many of our customers’ supplier selection and evaluation processes, but also highlights the steady progress we are making year over year.
As JAS continues its sustainability journey, the company remains focused on driving measurable improvements across its operations and working closely with customers and partners to reduce environmental impact and achieve shared sustainability goals.
Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.